Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Tumor Vaccines Using Gpi Linked Molecules
Segal, Andrew H.
Genitrix, LLC, Cambridge, MA, United States
Search 10 grants from Andrew Segal
Search grants from Genitrix, LLC
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Regulation of DNA synthesis in response to DNA damage
Endothelial lipid droplet turnover and regulation of metabolic function
Genes and Environment Initiative in Glaucoma
Intrauterine Growth Restriction at High Altitudes
Cancer Communications System
Recently added grants:
Salmonella-specific Th1 cell function and residence
Challenges in beta-Lactamase Mediated Resistance
An automated platform for direct-from-specimen identification of pathogens common in endocarditis
Evaluating the Neurocomputational Mechanisms of Explore-Exploit Decision Making in Older Adults
Biosynthetic studies and development of ribomimetic-based anti-infectives
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
3R43CA074665-01A1S1
Application #
6021665
Study Section
Special Emphasis Panel (ZRG2 (02))
Program Officer
Reynolds, Craig W
Project Start
1997-09-30
Project End
1999-06-30
Budget Start
1997-09-30
Budget End
1999-06-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
Genitrix, LLC
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Related projects
NIH 1999
R43 CA
Development of Tumor Vaccines Using Gpi Linked Molecules
Segal, Andrew H. / Genitrix, LLC
NIH 1997
R43 CA
Development of Tumor Vaccines Using Gpi-Linked Molecules
Segal, Andrew H. / Genitrix, LLC
Comments
Be the first to comment on Andrew Segal's grant